Panoramic view of Harrington Discovery Institute

Scientific Advisory Board

The Harrington Discovery Institute Scientific Advisory Board brings together some of the nation’s most accomplished medical innovators. Under the leadership of Jonathan Stamler, MD, President of the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, the Scientific Advisory Board members review proposals for the Harrington Discovery Institute’s Scholar-Innovator Award and select awardees based on quality of science, innovation and potential for impact. The Scientific Advisory Board also partners with the American Society for Clinical Investigation (ASCI) leadership to select the winner of The Harrington Prize for Innovation in Medicine.

Jonathan Stamler, MD

President of Harrington Discovery Institute, University Hospital Health System, Robert S. and Sylvia K. Reitman Family Foundation Distinguished Chair and Professor of Medicine and Professor of Biochemistry, Director of the Institute for Transformative Molecular Medicine, Case Western Reserve University

David Ginsburg, MD

Distinguished University Professor of Internal Medicine and Human Genetics; University of Michigan Medical School; Howard Hughes Medical Institute Investigator

William G. Kaelin, Jr., MD

Sidney Farber Professor of Medicine, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School; Investigator, Howard Hughes Medical Institute

Barbara B. Kahn, MD

George R. Minot Professor of Medicine at Harvard Medical School, Vice-Chair for Research Strategy in the Department of Medicine at Beth Israel Deaconess Medical Center, and Senior Associate Member of the Broad Institute of MIT and Harvard

Andrew R. Marks, MD

Chairman, Department of Physiology and Cellular Biophysics, Columbia University Medical Center; Founding Director, Wu Center for Molecular Cardiology

Solomon H. Snyder MD, DSc, D.Phil.

Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry, The Johns Hopkins University

Michael Welsh, MD

Director, Pappajohn Biomedical Institute and the University of Iowa Cystic Fibrosis Research Center; Roy J. Carver Chair in Biomedical Research; Professor of Internal Medicine, Molecular Physiology and Biophysics, and Neurosurgery, University of Iowa; Investigator, Howard Hughes Medical Institute

Doug R. Lowy, MD

Principal Deputy Director, National Cancer Institute, National Institutes of Health

Charles Sawyers, MD

Chairman, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, Howard Hughes Medical Institute Investigator

Scientific Advisory Board

Jonathan Stamler, MD

David Ginsburg, MD

William G. Kaelin, Jr., MD

Barbara B. Kahn, MD

Andrew R. Marks, MD

Solomon H. Snyder MD, DSc, D.Phil.

Michael Welsh, MD

Federal Government Liaison

Doug R. Lowy, MD

Emeritus

Charles Sawyers, MD

The Harrington Project for Discovery & Development

Discover

Advance

Commercialize

Breakthrough Medicine